Total Payments
$6,915
2024 Payments
$1,208
Companies
42
Transactions
405
Medicare Patients
17,693
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$6,876 (99.4%)
Education$39.34 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,876 | 399 | 99.4% |
| Education | $39.34 | 6 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $894.34 | 58 | $0 (2024) |
| ABBVIE INC. | $877.49 | 65 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $687.96 | 23 | $0 (2024) |
| Amgen Inc. | $509.69 | 32 | $0 (2024) |
| Allergan, Inc. | $410.59 | 22 | $0 (2021) |
| Abbott Laboratories | $393.05 | 18 | $0 (2024) |
| Mylan Specialty L.P. | $374.06 | 24 | $0 (2024) |
| PFIZER INC. | $340.32 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $303.50 | 21 | $0 (2024) |
| Lilly USA, LLC | $286.91 | 22 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,208 | 70 | ABBVIE INC. ($265.98) |
| 2023 | $959.66 | 66 | AbbVie Inc. ($209.67) |
| 2022 | $1,387 | 78 | Novo Nordisk Inc ($226.37) |
| 2021 | $1,610 | 95 | AbbVie Inc. ($195.34) |
| 2020 | $1,247 | 69 | Allergan, Inc. ($318.29) |
| 2019 | $503.30 | 27 | Novo Nordisk Inc ($113.94) |
All Payment Transactions
405 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/19/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: NEUROLOGY | ||||||
| 12/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.12 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Neurology | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: PAIN | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Obesity | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.34 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.55 | General |
| 10/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Neurology | ||||||
| 10/07/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Neuromodulation | ||||||
| 09/25/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Neuromodulation | ||||||
| 09/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/18/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: Neurology | ||||||
| 09/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: VACCINES | ||||||
| 08/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 58 | 3,224 | 5,053 | $646,398 | $244,639 |
| 2022 | 65 | 6,712 | 9,853 | $1.1M | $437,970 |
| 2021 | 65 | 4,892 | 7,036 | $738,865 | $323,601 |
| 2020 | 45 | 2,865 | 3,778 | $396,313 | $158,111 |
Total Patients
17,693
Total Services
25,720
Medicare Billing
$1.2M
Procedure Codes
233
All Medicare Procedures & Services
233 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 606 | 1,098 | $278,408 | $89,159 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 167 | 167 | $41,073 | $21,236 | 51.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 50 | 50 | $15,141 | $14,130 | 93.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 54 | 76 | $27,150 | $10,155 | 37.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 59 | 59 | $19,522 | $9,599 | 49.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 48 | 239 | $23,747 | $9,056 | 38.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 40 | 200 | $21,520 | $7,710 | 35.8% |
| 99493 | Follow-up psychiatric collaborative care management, subsequent calendar month, first 60 minutes | Office | 2023 | 19 | 48 | $13,536 | $5,109 | 37.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 54 | 111 | $13,939 | $4,602 | 33.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 60 | 60 | $9,584 | $4,543 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 75 | $13,462 | $4,381 | 32.5% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 165 | 165 | $8,580 | $4,212 | 49.1% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 70 | 110 | $11,817 | $4,186 | 35.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 26 | 27 | $10,795 | $3,868 | 35.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 20 | 21 | $7,842 | $3,239 | 41.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 16 | 17 | $8,194 | $3,201 | 39.1% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 150 | 150 | $5,550 | $2,718 | 49.0% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 83 | 105 | $5,430 | $2,646 | 48.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $9,900 | $2,635 | 26.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 12 | $5,829 | $2,607 | 44.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $4,606 | $2,282 | 49.5% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 26 | 26 | $6,060 | $2,210 | 36.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 106 | 220 | $7,999 | $2,203 | 27.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 38 | 42 | $5,256 | $2,069 | 39.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 66 | 66 | $3,951 | $2,006 | 50.8% |
About Dr. Joshua Bloomberg, DO
Dr. Joshua Bloomberg, DO is a Internal Medicine healthcare provider based in Tempe, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2012. The National Provider Identifier (NPI) number assigned to this provider is 1881966448.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Bloomberg, DO has received a total of $6,915 in payments from pharmaceutical and medical device companies, with $1,208 received in 2024. These payments were reported across 405 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($6,876).
As a Medicare-enrolled provider, Bloomberg has provided services to 17,693 Medicare beneficiaries, totaling 25,720 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 233 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Tempe, AZ
- Active Since 01/29/2012
- Last Updated 09/10/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1881966448
Products in Payments
- Ozempic (Drug) $533.82
- FARXIGA (Drug) $447.12
- VRAYLAR (Drug) $419.48
- BOTOX (Biological) $397.02
- EVENITY (Biological) $292.59
- UBRELVY (Drug) $262.95
- Yupelri (Drug) $258.26
- XARELTO (Drug) $246.47
- TRULICITY (Drug) $185.49
- ENTRESTO (Drug) $177.96
- Rybelsus (Drug) $168.14
- SHINGRIX (Biological) $165.61
- Dexcom G6 Transmitter (Medical Supply) $141.20
- PREVNAR 20 (Biological) $132.85
- Aimovig (Biological) $127.40
- NURTEC ODT (Drug) $122.96
- YUPELRI (Drug) $115.80
- PROCLAIM (Device) $114.11
- QULIPTA (Drug) $97.25
- Leqembi (Drug) $97.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tempe
Jeffrey Hoodin, M.d, M.D
Internal Medicine — Payments: $206,801
Internal Medicine $206,801
Dr. Robert Bloomberg, Md, MD
Internal Medicine — Payments: $13,899
Internal Medicine $13,899
Dr. Carlos Echevarria, Md, Mmm, MD, MMM
Internal Medicine — Payments: $13,214
Internal Medicine $13,214
Dr. Kenneth Anaeme, Md, MD
Internal Medicine — Payments: $10,337
Internal Medicine $10,337
Dhaval Shah, M.d, M.D
Internal Medicine — Payments: $8,039
Internal Medicine $8,039
Dr. Shilpa Bhatnagar, M. D, M. D
Internal Medicine — Payments: $7,050
Internal Medicine $7,050